SEARCH

SEARCH BY CITATION

References

  • 1
    Pai RK, Longacre TA. Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification. Adv Anat Pathol 2005;12:291311.
  • 2
    Ronnett BM, Kurman RJ, Zahn CM et al. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol 1995;26:50924.
  • 3
    Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “Pseudomyxoma peritonei”. Am J Surg Pathol 1995;19:1390408.
  • 4
    Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92:8591.
  • 5
    Pranesh N, Menasce LP, Wilson MS, O’Dwyer ST. Pseudomyxoma peritonei: unusual origin from an ovarian mature teratoma. J Clin Pathol 2005;58:11157.
  • 6
    Ronnett BM, Shmookler BM, Diener-West M, Sugarbaker PH, Kurman RJ. Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 1997;16:19.
  • 7
    Guerrieri C, Franlund B, Fristedt S, Gillooley JF, Boeryd B. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression. Hum Pathol 1997;28:103945.
  • 8
    Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol 1999;154:184955.
  • 9
    Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003;27:6507.
  • 10
    Van Ruth S, Acherman YIZ, Van De Vijver MJ, Hart AAM, Verwaal VJ, Zoetmulder FAN. Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 2003;29:6828.
  • 11
    Young RH. Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms [review]. Seminars in Diagnostic Pathology 2004;21:13450.
  • 12
    Shen DH, Ng TY, Khoo US et al. Pseudomyxoma peritonei: a heterogenous disease. Int J Gynecol Obstet 1998;62:17382.
  • 13
    Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 2004;25:4114.
  • 14
    O’Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol 2002;15:95872.
  • 15
    O’Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 2002;161:55164.
  • 16
    Nonaka D, Kusamura S, Baratti D et al. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases. Histopathology 2006;49:3817.
  • 17
    Cuatrecasas M, Matias-Guiu X, Prat J et al. Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei: a clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations. Am J Surg Pathol 1996;20:73946.
  • 18
    Matias-Guiu X, Lagarda H, Catasus L et al. Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int J Gynecol Pathol 2002;21:20511.
  • 19
    Maheshwari V, Tsung A, Lin Y, Zeh HJ III, Finkelstein SD, Bartlett DL. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix. Ann Surg Oncol 2006;13:16106.
  • 20
    Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
  • 21
    Mann WJ Jr, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer 1990;66:163640.
  • 22
    Hopkins ML, Depetrillo AD, Le T, Fung KF. Pseudomyxoma peritonei: a case series and review of the literature. Int J Gynecol Cancer 2005;15:326.
  • 23
    Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol 1999;23:61735.
  • 24
    Liapis A, Michailidis E, Bakas P, Kondi-Pafiti A, Creatasas G. Mucinous tumors of the appendix presenting as primary tumors of the ovary. Report of two cases. Eur J Gynaecol Oncol 2004;25:1135.
  • 25
    Bradley RF, Stewart JH IV, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:5519.
  • 26
    Marquette S, Amant F, Vergote I, Moerman P. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report. Int J Gynecol Pathol 2006;25:3403.
  • 27
    Vang R, Gown AM, Barry TS et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol 2006;30:11309.
  • 28
    Gipson IK, Ho SB, Spurr-Michaud SJ et al. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod 1997;56:9991011.
  • 29
    Dekker J, Rossen JW, Buller HA, Einerhand AW. The MUC family: an obituary. Trends Biochem Sci 2002;27:12631.
  • 30
    Feng H, Ghazizadeh M, Konishi H et al. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas. Jpn J Clin Oncol 2002;32:5259.
  • 31
    Lau SK, Weiss LM, Chu PG. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol 2004;122:619.
  • 32
    Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol 2000;31:6727.
  • 33
    Lee MJ, Lee HS, Kim WH et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 2003;16:40310.